BELOVA: a Non-Interventional Study to Collect Data on the Safety and Efficacy of Frontline Bevacizumab Treatment in Ovarian Cancer Patients 70 Years and Older.
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2016
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Adverse reactions
- Acronyms BELOVA
- Sponsors Roche
- 18 Jul 2016 Status changed from not yet recruiting to recruiting.
- 24 Mar 2015 New trial record